Advanced Accelerator Applications Articles
AAA boosts European radiopharma manufacturing network buying Barnatron and Cadisa of Spain
29 January 2013
Lutathera first MNM theragnostic drug, enters Ph III in cancer patients with midgut carcinoid
20 September 2012
Showing 1-4 of 4 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Is the diabetes market facing a blockbuster-free future?
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
